UNIGE document Scientific Article
previous document  unige:78631  next document
add to browser collection

Quelle insuline pour quel patient en 2014 ?

Published in Revue médicale suisse. 2014, vol. 10, no. 433, p. 1230-1234
Abstract Initiation of insulin treatment is a major step in the care of type 2 diabetic patients; it implicates a thorough discussion with the patient, therapeutic education and objectives shared by both physician and patient. The standard is an injection of basal insulin per day with either NPH insulin or a basal insulin analogue, such as detemir, glargine or degludec. The basal analogues have less side effects, weight gain and hypoglycemia, a more reproductible profile and a longer duration of action compared to NPH insulin. The injection can be made in the evening or in the morning depending on the dose and the glycemic profile. Oral antidiabetics can be maintained. More complicated insulin regimen are sometimes necessary but often induce more side effects with less compliance and little additional benefits.
Keywords Choice BehaviorDiabetes Mellitus, Type 2/drug therapyHumansHypoglycemic Agents/therapeutic useInsulin/therapeutic usePractice Guidelines as Topic
PMID: 25004767
Full text
Article (Published version) (598 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group Diabète et régulation des gènes (36)
(ISO format)
PHILIPPE, Jacques. Quelle insuline pour quel patient en 2014 ?. In: Revue médicale suisse, 2014, vol. 10, n° 433, p. 1230-1234. https://archive-ouverte.unige.ch/unige:78631

237 hits

0 download


Deposited on : 2015-12-14

Export document
Format :
Citation style :